Eumetopias jubatus (Steller sea lion): 114206181
Help
Entry
114206181 CDS
T07240
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X1
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
eju
Eumetopias jubatus (Steller sea lion)
Pathway
eju01524
Platinum drug resistance
eju04010
MAPK signaling pathway
eju04115
p53 signaling pathway
eju04148
Efferocytosis
eju04210
Apoptosis
eju04215
Apoptosis - multiple species
eju04623
Cytosolic DNA-sensing pathway
eju04650
Natural killer cell mediated cytotoxicity
eju04657
IL-17 signaling pathway
eju04668
TNF signaling pathway
eju04726
Serotonergic synapse
eju04932
Non-alcoholic fatty liver disease
eju04933
AGE-RAGE signaling pathway in diabetic complications
eju04936
Alcoholic liver disease
eju05010
Alzheimer disease
eju05012
Parkinson disease
eju05014
Amyotrophic lateral sclerosis
eju05016
Huntington disease
eju05020
Prion disease
eju05022
Pathways of neurodegeneration - multiple diseases
eju05132
Salmonella infection
eju05133
Pertussis
eju05134
Legionellosis
eju05145
Toxoplasmosis
eju05146
Amoebiasis
eju05152
Tuberculosis
eju05160
Hepatitis C
eju05161
Hepatitis B
eju05162
Measles
eju05163
Human cytomegalovirus infection
eju05164
Influenza A
eju05165
Human papillomavirus infection
eju05167
Kaposi sarcoma-associated herpesvirus infection
eju05168
Herpes simplex virus 1 infection
eju05169
Epstein-Barr virus infection
eju05170
Human immunodeficiency virus 1 infection
eju05200
Pathways in cancer
eju05203
Viral carcinogenesis
eju05205
Proteoglycans in cancer
eju05206
MicroRNAs in cancer
eju05210
Colorectal cancer
eju05222
Small cell lung cancer
eju05416
Viral myocarditis
eju05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
eju00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
114206181 (CASP3)
04668 TNF signaling pathway
114206181 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
114206181 (CASP3)
09143 Cell growth and death
04210 Apoptosis
114206181 (CASP3)
04215 Apoptosis - multiple species
114206181 (CASP3)
04115 p53 signaling pathway
114206181 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
114206181 (CASP3)
04650 Natural killer cell mediated cytotoxicity
114206181 (CASP3)
04657 IL-17 signaling pathway
114206181 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
114206181 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
114206181 (CASP3)
05206 MicroRNAs in cancer
114206181 (CASP3)
05205 Proteoglycans in cancer
114206181 (CASP3)
05203 Viral carcinogenesis
114206181 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
114206181 (CASP3)
05222 Small cell lung cancer
114206181 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
114206181 (CASP3)
05161 Hepatitis B
114206181 (CASP3)
05160 Hepatitis C
114206181 (CASP3)
05164 Influenza A
114206181 (CASP3)
05162 Measles
114206181 (CASP3)
05168 Herpes simplex virus 1 infection
114206181 (CASP3)
05163 Human cytomegalovirus infection
114206181 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
114206181 (CASP3)
05169 Epstein-Barr virus infection
114206181 (CASP3)
05165 Human papillomavirus infection
114206181 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
114206181 (CASP3)
05133 Pertussis
114206181 (CASP3)
05134 Legionellosis
114206181 (CASP3)
05152 Tuberculosis
114206181 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
114206181 (CASP3)
05145 Toxoplasmosis
114206181 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
114206181 (CASP3)
05012 Parkinson disease
114206181 (CASP3)
05014 Amyotrophic lateral sclerosis
114206181 (CASP3)
05016 Huntington disease
114206181 (CASP3)
05020 Prion disease
114206181 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
114206181 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
114206181 (CASP3)
05416 Viral myocarditis
114206181 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
114206181 (CASP3)
04932 Non-alcoholic fatty liver disease
114206181 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
114206181 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
114206181 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
eju01002
]
114206181 (CASP3)
Enzymes [BR:
eju01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
114206181 (CASP3)
Peptidases and inhibitors [BR:
eju01002
]
Cysteine peptidases
Family C14: caspase family
114206181 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
114206181
NCBI-ProteinID:
XP_027955645
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTEHSVDAKSIKNSEIKTLHGSKSVDSGMSLDNSYKMDYPEMGLCIIINNKNFHRSTG
MTPRSGTDVDAANLRETFTNLKYEVRNKNDLTCEEILELMDSVSKEDHSKRSSFVCVLLS
HGDEGIIFGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGADD
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCTMLKLYAHKLEFMHILTRVN
RKVATEFESFSLDSAFHGKKQIPCIVSMLTKELYLYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaacactcagtggatgcaaaatccattaaaaattcagaaataaagacc
ttacatggaagcaaatcagtggactctggaatgtccttggacaacagttataaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcatagaagtactgga
atgacacctcgatccggtacagatgtagatgcagcaaacctccgggaaacattcacaaac
ttgaaatacgaagtcaggaataaaaatgatctcacatgcgaagaaattttggaattaatg
gacagtgtctctaaagaagatcacagcaaaaggagcagttttgtttgcgtgcttctaagc
catggggatgaaggaataatttttggaacaaatggacctgttgacctgaaaaaattaaca
ggtttcttcagaggggattactgtcgaagtctgactggaaaacccaaacttttcattatt
caggcctgccgaggcacagaactggactgcggtattgagacagacagcggagccgatgat
gacatggcctgtcagaaaataccagttgaagcagacttcttgtatgcctattctacggcc
cctggttactattcctggcgaaattcaaaggacggatcctggttcatccagtcactttgt
acgatgctgaaactatatgctcacaagcttgaatttatgcacattcttactcgggttaac
cgaaaggtagccacagaatttgagtccttttctcttgattctgcttttcatggaaagaaa
cagattccgtgtattgtgtctatgctaacaaaagaactgtatctttatcactaa
DBGET
integrated database retrieval system